Terms: = Gastric cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Treatment
66 results:
1. Effects of Extended Fixation on Advanced gastric cancer HER2 Status Assessment Using IHC and FISH.
Kondo J; Yoshino S; Iida M; Takeda S; Nakashima C; Watanabe Y; Nishiyama M; Tokumitsu Y; Shindo Y; Nishimura T; Suzuki N; Hoshii Y; Itoh H; Nagano H
Anticancer Res; 2024 Feb; 44(2):621-630. PubMed ID: 38307565
[TBL] [Abstract] [Full Text] [Related]
2. [Mechanism of Astragali Radix-Curcumae Rhizoma in treating gastric cancer based on network pharmacology and experimental verification].
Tan XY; Tao J; Zhang Y; Gu RX
Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):5056-5067. PubMed ID: 37802848
[TBL] [Abstract] [Full Text] [Related]
3. Development and validation of a prognostic score to identify the optimal candidate for preemptive TIPS in patients with cirrhosis and acute variceal bleeding.
Lv Y; Bai W; Zhu X; Xue H; Zhao J; Zhuge Y; Sun J; Zhang C; Ding P; Jiang Z; Zhu X; Ren W; Li Y; Zhang K; Zhang W; Li K; Wang Z; Luo B; Li X; Yang Z; Guo W; Xia D; Xie H; Pan Y; Yin Z; Fan D; Han G
Hepatology; 2024 Jan; 79(1):118-134. PubMed ID: 37594323
[TBL] [Abstract] [Full Text] [Related]
4. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
[No Abstract] [Full Text] [Related]
5. Personalized medicine with germline pathogenic variants: Importance of population- and region-wide evidence.
Usui Y; Momozawa Y
Cancer Sci; 2023 Oct; 114(10):3816-3824. PubMed ID: 37530079
[TBL] [Abstract] [Full Text] [Related]
6. Hereditary breast and ovarian cancer: from genes to molecular targeted therapies.
Ponti G; De Angelis C; Ponti R; Pongetti L; Losi L; Sticchi A; Tomasi A; Ozben T
Crit Rev Clin Lab Sci; 2023 Dec; 60(8):640-650. PubMed ID: 37455374
[TBL] [Abstract] [Full Text] [Related]
7. Uncommon variants detected via hereditary cancer panel and suggestions for genetic counseling.
Özdemir Z; Çevik E; Öksüzoğlu ÖBÇ; Doğan M; Ateş Ö; Esin E; Bilgetekin İ; Demirci U; Köseoğlu Ç; Topal A; Karadurmuş N; Erdem HB; Bahsi T
Mutat Res; 2023; 827():111831. PubMed ID: 37453313
[TBL] [Abstract] [Full Text] [Related]
8. The BRCAness Landscape of cancer.
Guo M; Wang SM
Cells; 2022 Dec; 11(23):. PubMed ID: 36497135
[TBL] [Abstract] [Full Text] [Related]
9. Trend in gastric cancer Mortality in Kazakhstan.
Igissinov N; Taszhanov R; Telmanova Z; Baibusunova A; Rustemova K; Bilyalova Z; Igissinova G; Kudaibergenova I; Kozhakhmetov S; Orazbayev S; Azhetova Z; Nurtazinova G; Sayakov U; Dzhumabayeva F; Kulayev K; Idrissov K; Kuandykov T; Mutagirov V; Shapambayev N
Asian Pac J Cancer Prev; 2022 Nov; 23(11):3779-3789. PubMed ID: 36444591
[TBL] [Abstract] [Full Text] [Related]
10. MC180295 Inhibited Epstein-Barr Virus-Associated gastric Carcinoma Cell Growth by Suppressing DNA Repair and the Cell Cycle.
Fujii T; Nishikawa J; Fukuda S; Kubota N; Nojima J; Fujisawa K; Ogawa R; Goto A; Hamabe K; Hashimoto S; Wai AP; Iizasa H; Yoshiyama H; Sakai K; Suehiro Y; Yamasaki T; Takami T
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142506
[TBL] [Abstract] [Full Text] [Related]
11. Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience.
Gerratana L; Movarek M; Wehbe F; Katam N; Mahalingam D; Donahue J; Shah A; Chae YK; Mulcahy M; Tsarwhas D; Villaflor V; Kalyan A; Hussein M; Patel J; Chandra S; Platanias LC; Gradishar W; Cristofanilli M; Behdad A
JCO Precis Oncol; 2022 Jun; 6():e2100289. PubMed ID: 35772051
[TBL] [Abstract] [Full Text] [Related]
12. Effect of E-cadherin on Prognosis of Colorectal cancer: A Meta-Analysis Update.
Chang K; Jiang L; Sun Y; Li H
Mol Diagn Ther; 2022 Jul; 26(4):397-409. PubMed ID: 35732878
[TBL] [Abstract] [Full Text] [Related]
13. Comprehensive Analysis of Epigenetic Associated Genes with Differential Gene Expression and Prognosis in gastric cancer.
An S; Li X; Li B; Li Y
Comb Chem High Throughput Screen; 2023; 26(3):527-538. PubMed ID: 35570548
[TBL] [Abstract] [Full Text] [Related]
14. DNA damage, cell cycle perturbation and cell death by naphthalene diimide derivative in gastric cancer cells.
Gurung SK; Kumari S; Dana S; Mandal K; Sen S; Mukhopadhyay P; Mondal N
Chem Biol Interact; 2022 May; 358():109881. PubMed ID: 35307378
[TBL] [Abstract] [Full Text] [Related]
15. Double heterozygotes of brca1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications.
Laish I; Friedman E; Levi-Reznick G; Kedar I; Katz L; Levi Z; Halpern N; Parnasa S; Abu-Shatya A; Half E; Goldberg Y
Breast Cancer Res Treat; 2021 Aug; 188(3):685-694. PubMed ID: 34086170
[TBL] [Abstract] [Full Text] [Related]
16. Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer.
Jin C; Jiang Y; Yu H; Wang W; Li B; Chen C; Yuan Q; Hu Y; Xu Y; Zhou Z; Li G; Li R
Br J Surg; 2021 May; 108(5):542-549. PubMed ID: 34043780
[TBL] [Abstract] [Full Text] [Related]
17. A Nomogram Based on Clinicopathologic Features and Preoperative Hematology Parameters to Predict Occult Peritoneal Metastasis of gastric cancer: A Single-Center Retrospective Study.
Yang C; Yang Y; Huang X; Li H; Cheng H; Tong S; Zheng Y
Dis Markers; 2020; 2020():1418978. PubMed ID: 33376558
[TBL] [Abstract] [Full Text] [Related]
18. Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure.
Lin Z; Huang L; Li S; Gu J; Cui X; Zhou Y
Sci Rep; 2020 Dec; 10(1):21530. PubMed ID: 33299035
[TBL] [Abstract] [Full Text] [Related]
19. cancer Previvors in an Active Duty Service Women Population: An Opportunity for Prevention and Increased Force Readiness.
Lovejoy LA; Turner CE; Shriver CD; Ellsworth RE
Mil Med; 2021 Jul; 186(7-8):e737-e742. PubMed ID: 33206196
[TBL] [Abstract] [Full Text] [Related]
20. Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study.
Domchek SM; Postel-Vinay S; Im SA; Park YH; Delord JP; Italiano A; Alexandre J; You B; Bastian S; Krebs MG; Wang D; Waqar SN; Lanasa M; Rhee J; Gao H; Rocher-Ros V; Jones EV; Gulati S; Coenen-Stass A; Kozarewa I; Lai Z; Angell HK; Opincar L; Herbolsheimer P; Kaufman B
Lancet Oncol; 2020 Sep; 21(9):1155-1164. PubMed ID: 32771088
[TBL] [Abstract] [Full Text] [Related]
[Next]
